All Stories
Lilly's oral obesity drug shows promising safety and tolerability
Lilly's experimental oral obesity drug, aleniglipron, helped patients lose up to 12.
Early Hospice Questions Families Can Bring to Dynamic In-Home Care
Families often face difficult questions about hospice care, focusing on whether the patient's care should shift from cure to comfort. Dynamic In-Home Care helps families navigate these initial conversations by addressing physician involvement, eligibility, and a personalized plan of care.
Retatrutide's Triple Hormone Action Aims to Revolutionize Obesity Treatment
Patients on the highest dose of retatrutide lost an average of 28% of their body weight over 80 weeks in the latest study, a result mirroring bariatric surgery, according to the South Florida Reporter
Africa CDC, WHO Launch $518M Ebola Plan in Central Africa
An ongoing Ebola outbreak, fueled by the Bundibugyo virus, has already claimed 63 lives and infected approximately 400 people.
HHS Authorizes Experimental Ebola Therapy for High-Risk Exposures
The U.S. Department of Health and Human Services (HHS) has authorized an experimental monoclonal antibody treatment, MBP-134, for Americans facing high-risk Ebola exposures. This move sidesteps tradit
AI Leaders Urge Stricter Synthetic Biology Regulation
Leaders from OpenAI, Microsoft, and Google DeepMind have publicly urged governments to enact stricter regulations for synthetic biology.
Legend Biotech stock surges on strong Q1 CAR T-cell therapy results
Legend Biotech's stock recently jumped 42% following new data, propelled by early clinical successes in difficult-to-treat cancers and robust sales of its existing CAR-T therapy, CARVYKTI, according t
A First Appointment Guide to Compassionate Health Med Spa Nonsurgical Treatments
Deciding to explore nonsurgical aesthetic treatments can feel overwhelming, especially when you are unsure which service best addresses your concerns. For those considering their options, the first appointment is not abo…
Alnylam partners with Inceptive Nucleics for AI-driven RNAi therapeutics
Alnylam Pharmaceuticals, a leader in RNAi therapeutics, just committed $30 million upfront and up to $2 billion to Silicon Valley biotech startup Inceptive Nucleics.
Trump administration removes job protections for NIH officials
The National Institute of Mental Health (NIMH), typically funding nearly 1,000 new research awards annually, is on track to fund only 50 for the entire fiscal year.
String Theory's Theoretical Insights for Quantum Research
Decades after its inception, string theory continues to generate groundbreaking mathematical insights, yet remains a theory without a single direct experimental confirmation.
Medicare Unveils $50 Monthly Cap on Obesity Drugs
Starting in July, eligible Medicare beneficiaries will access GLP-1 weight-loss medications for a monthly cost of just $50, according to The Motley Fool .
Turkey's Hair Transplant Industry 'Hacks' Global Market
A hair transplant procedure costing up to $30,000 in the U.S. can be secured for as little as $3,000 in Turkey, often including travel and accommodation. This price disparity has made Turkey the global leader in hair restoration, effectively 'hacking' the global industry.
Finding the Best Cosmetic Dentist in Tukwila? A Guide to Lance Timmerman, DMD's Approach
Choosing a cosmetic dentist involves more than just procedures; it requires experience, advanced training, and artistic judgment to create natural results. Lance Timmerman, DMD in Tukwila offers a patient-focused approach, combining advanced cosmetic dentistry with personalized care for lasting smile transformations.
Revolution Medicines' Experimental Pancreatic Cancer Drug Shows Promise
Revolution Medicines' experimental drug daraxonrasib doubled the median overall survival for patients with metastatic pancreatic cancer to 13.2 months in its pivotal Phase 3 trial.
BioNTech, Pfizer Share Bispecifics Data at ASCO
BioNTech's BNT142 achieved 7 RECIST 1.
Bristol Myers Squibb shows strong multiple myeloma data
In a significant development for multiple myeloma patients, Bristol Myers Squibb's mezigdomide triplet demonstrated a median progression-free survival of 18 months, more than doubling the 8.
Bepirovirsen data shows functional cure in 19% of hepatitis B patients
An experimental hepatitis B treatment achieved a 'functional cure' in nearly 1 in 5 patients during its pivotal Phase 3 studies, a significant stride against a chronic viral infection that afflicts mi
With HDHPs Rising, Is Diagnostic Orders Direct the Smartest Way to Pay for Imaging?
With the rise of high-deductible health plans (HDHPs), patients are increasingly paying out-of-pocket for diagnostic imaging. Platforms like Diagnostic Orders Direct offer a faster and more affordable alternative by allowing patients to bypass traditional referrals and shop for cash prices.
Trump Drug Pricing Deals Face Test as New Drugs Launch
The Medicare negotiated price for semaglutide, the active ingredient in blockbuster drugs like Ozempic, is $274 under the Inflation Reduction Act.
New drug Bepirovirsen functionally cures hepatitis B in some patients
In two late-stage clinical trials, GSK's experimental drug Bepirovirsen achieved a functional cure for 19% of patients with chronic hepatitis B, a disease that has long resisted effective treatment.
Poland's economy booms, but science funding lags behind
Despite Poland's economy growing by an estimated 3.
Scientists Achieve Bottom-Up Synthesis of Molecular Nanodiamonds
Imagine diamonds, just 3 to 4 nanometers, engineered with atomic precision to glow for quantum computers or illuminate biological processes.
Plasma beam tech could revolutionize Mars laundry
A purple plasma beam reduced spore colonies on cotton fabric from 250,000 colonies per milliliter to about 60,000 in recent tests, according to New Scientist .